AstraZeneca 거래 AZN

매도
 매수

AstraZeneca 실시간 차트

5m 15m 30m 1h 4h 1d 1w

상품 기초

Weekly Search
Weekly
Daily
날짜 종료 변경 변동(%) 열기 높음 낮음

최신 뉴스

Tommy Yap 2025 Apr 16, 16:00

Morning Note: UK Inflation Data, US Retail Sales Loom, BoC Rate Expected to Hold

Morning Note USD CAD GBP
Frances Wang 2025 Apr 15, 16:00

Crude oil price today: How much is crude oil per barrel today?

Commodities
Frances Wang 2025 Apr 15, 16:00

Stock market index: Russell 2000 Index Swings Amid Tariff Fears

Indices
Tommy Yap 2025 Apr 14, 16:00

Morning Note: Oil Rises on Tariff Relief Hint; UK Jobs in Focus; Canada CPI Looms

Morning Note Commodities
Frances Wang 2025 Apr 13, 16:00

Bitcoin price today: what’s going on with Solana, XRP, and Dogecoin?

Cryptocurrencies
Frances Wang 2025 Apr 13, 16:00

Stock Market Today: Dow, S&P 500, and Nasdaq Futures Start Off Stronger

Indices Stocks
Tommy Yap 2025 Apr 13, 16:00

Morning Note: Tariff Chaos Shakes Dollar Confidence; BoE Cautious; Yen Gains

Morning Note Forex
Tommy Yap 2025 Apr 12, 16:00

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Forex Indices

정보

스프레드

63.60

스프레드(%)

0.6214 %

레버리지

1:10

익일 이자 매수

-0.0590 %

익일 이자 매도

-0.0299 %

통화

PNC

거래 시간

시장 폐장

목요일

07:01 - 10:59

화요일

07:01-10:59

화요일

11:03-15:29

수요일

07:01-10:59

수요일

11:03-15:29

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

159358500864

발행 주식 수

1550179968

수익 날짜 (다음)

0000-00-00

배당수익률

배당락일

2025-02-20

예상 연간 배당금

2.46

예상 연간 배당수익률

0.0238

EPS

3.44

이 상품에 대해 자세히 알아보기

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

관련 상품

자산
매도
매수
변동(%)

지금 거래하기

지금 거래하기

지금 거래하기

지금 거래하기
view_all_instruments
Trustpilot